We are live on ! Find out more
MNOV icon

MediciNova

16 hedge funds and large institutions have $4.33M invested in MediciNova in 2013 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

7% more funds holding

Funds holding: 1516 (+1)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

17% less capital invested

Capital invested by funds: $5.25M → $4.33M (-$912K)

Holders
16
Holders Change
+1
Holders Change %
+6.67%
% of All Funds
0.46%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
2
Increased
3
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

MNOV Hedge Fund Activity: Q4 2013 in Review

16 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q4 2013, worth a combined $4.33M — down 17% from $5.25M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new MNOV positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Macquarie Group, opening a new position worth an estimated $11.8K. The largest seller was First New York Securities, exiting entirely with an estimated $73K sold.

  • 16 institutional investors held MediciNova (MNOV) as of Q4 2013, up from 15 in Q3 2013.
  • Funds reported $4.33M of MediciNova stock for Q4 2013, down 17% quarter-over-quarter.
  • 2 funds opened new MediciNova positions in Q4 2013 and 1 closed out, a net change of +1 holder.
  • The largest MediciNova buyer in Q4 2013 was Macquarie Group, an estimated $11.8K added.
  • The largest MediciNova seller in Q4 2013 was First New York Securities, an estimated $73K sold.

Based on aggregated 13F filings for Q4 2013.